Feature | Cardiovascular Business | June 07, 2024

In Memoriam: Stuart J. Connolly, MD

Stuart J. Connolly, MD

Stuart J. Connolly, MD


June 7, 2024 — It is with great sadness that the Diagnostic and Interventional Cardiology (DAIC) team has learned of the passing of arrhythmia medicine pioneer Stuart J. Connolly, MD, on June 2. 

According to his obituary published in the Hamilton Spectator, he completed a Bachelor of Philosophy at McGill University, then a Master of Philosophy at Fordham University, then returned to McGill where he graduated from medical school in 1977. Stuart met his wife Elaine during cardiology training at St Michael's Hospital in Toronto. After a year together they set off to Stanford University for post-doctoral training, then returned to join the faculty at McMaster University. In 1984 they moved to Lowville, where they would live for 36 years together until Elaine's passing in 2020. Stuart had a celebrated career as a cardiologist and researcher. His research impacted millions globally in the field of atrial fibrillation, stroke prevention and anticoagulation. He remained active in research until the very end of his life and is recognized worldwide as one of the most impactful clinical investigators in cardiac arrhythmia management, cited over 200,000 times to date. Among his over 400 publications, Stuart published 4 of his 26 New England Journal of Medicine papers in his final year. During his forty years at McMaster, Stuart founded the cardiac arrhythmia service and served as cardiology division director. Stuart mentored many promising clinicians and scientists at McMaster and at other institutions around the world, with great care and dedication, helping them to make meaningful and lasting impacts in their areas of investigation.

You can view the full tribute here.


Related Content

News | Cardiovascular Clinical Studies

Nov. 10, 2025 —Genomics, a science-led techbio company, has today announced new research that suggests polygenic risk ...

Home November 12, 2025
Home
News | Cardiovascular Clinical Studies

Oct. 21, 2025 – AskBio Inc., a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG ...

Home October 21, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 25, 2025 — Merck, known as MSD outside of the United States and Canada, has announced that new clinical trial and ...

Home August 25, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 18, 2025 — (Newswise) It’s often mistaken for a heart attack, but Takotsubo cardiomyopathy — previously known as ...

Home August 21, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 20, 2025 — A major international study published in Atherosclerosis* has found that routinely testing for ...

Home August 20, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 4, 2025 — Marea Therapeutics, Inc., a clinical-stage biotechnology company that develops next-generation medicines ...

Home August 04, 2025
Home
News | Cardiovascular Clinical Studies

July 16, 2025 — Medtronic has announced that the first patient has been enrolled in the PEripheral Onyx Liquid Embolic ...

Home July 22, 2025
Home
News | Cardiovascular Clinical Studies

June 11, 2025 — Bayer and the Broad Institute have have extended their research collaboration of 10 years by an ...

Home June 11, 2025
Home
News | Cardiovascular Clinical Studies

May 27, 2025 — Despite scientific advances in cardiovascular care, people in living in rural areas and other communities ...

Home May 27, 2025
Home
News | Cardiovascular Clinical Studies

May 20, 2025 — Shockwave Medical, Inc., part of Johnson & Johnson MedTechhas announced the 30-day primary endpoint ...

Home May 21, 2025
Home
Subscribe Now